Stomach Cancer Treatment Market by Treatment Type (Chemotherapy, Radiotherapy, Immunotherapy, Targeted Drug Therapy, and Surgery), by End User (Hospitals and Clinics, Specialized Cancer Treatment Centers, and Ambulatory Surgical Centers) - Global Outlook & Forecast 2022-2030
According to the deep-dive market assessment study by Growth+ Reports, the global stomach cancer treatment market is estimated at ~US$ 2.45 billion in 2021. The market is expected to witness a CAGR of ~ 14.70 % from 2022 to 2030.
Uncontrolled and abnormal growth of cells in the stomach lining leads to stomach cancer or gastric cancer. Factors attributing to the growth of the global stomach cancer treatment market are increased smoking and excessive alcohol consumption, a high rate of patients with obesity, and an unhealthy diet. However, strict laws and regulations that limit the availability of drugs to treat stomach cancer may restrict the market growth.
The increased number of patients with stomach cancer is due to factors such as unhealthy eating habits, high consumption of spicy and processed food, and high consumption of alcohol and smoking. For instance, the National Library of Medicine initiated a study between drinkers and smokers versus non-drinkers and non-smokers, which suggested that the risk of stomach cancer can rise with alcohol consumption and excessive smoking. According to the National Organization of Rare Diseases, there are four major types of gastric cancer: primary gastric lymphoma, gastrointestinal tumor, neuroendocrine tumors, and adenocarcinoma; among these, adenocarcinoma is the most common type of stomach cancer, and it is responsible for almost 90% of all gastric cancer cases. This type of cancer occurs in the glands that secrete mucus and gastric juices.
After smoking and drinking, obesity is the major cause of all types of gastric cancer, with rapid increase in obesity, risk of stomach cancer is also increasing correspondingly. Overweight leads to gastrointestinal cancer that have three main characteristics, abnormality in insulin signaling, chronic low-grade infection, and metabolism of sex hormones. A report from IARC (International Agency for Research in Cancer) suggested that excessive body fat can lead to sixteen or more types of cancer, which makes obesity the second most prominent cause of cancer after smoking. According to the IARC and the World Cancer Research Fund (WCRF), excess adiposity is a cause or a probable risk factor for gastrointestinal malignancies, including those of the pancreas, liver, oesophagus, colorectum, stomach, and gallbladder. This report also states that the reduction in body fat can reduce the risk of gastrointestinal cancers.
However, the availability of medications to treat stomach cancer is constrained by stringent laws and regulations, which may impede market expansion.
The global stomach cancer treatment Market has been divided into four regions: North America, Europe, Asia Pacific, and the Rest of the World (RoW). Due to large prevalence of stomach cancer in the Asia Pacific, this region has dominated the global stomach cancer treatment market. For instance, according to Globocan, in 2020, Asia saw 819,994 new instances of stomach cancer, accounting for 8.6 percent of all cancer cases, and the number is predicted to rise to 1,397,478 in the following five years. North America is also significantly contributing to the global stomach cancer treatment market due to a high number of patients, unhealthy eating habits, increased consumption of alcohol and tobacco, and also a large pool of geriatric population. Additionally, the American Cancer Society reports that adult populations are more likely to get stomach cancer, with 6 out of 10 patients being 65 years of age or older, the risk and burden of stomach cancer in North America are significantly high. European market for stomach cancer treatment will also show a rise in the forecast period. Swift adoption of modern technologies, supportive government programs like health reimbursements, and increased research and development are factors that contribute to the prominent position of Europe market.
This report has been analyzed from three perspectives: treatment type, end-user, and region. Based on the treatment type the global stomach cancer treatment market is divided into chemotherapy, radiotherapy, immunotherapy, targeted drug therapy, and surgery. Based on end users, hospitals and clinics, specialized cancer treatment centers, and ambulatory surgical centers collectively make up the global stomach cancer treatment market.